NEW YORK (360Dx) – The Technology Partnership (TTP), a British technology development firm, announced today that it has extended its alliance with Innova Biosciences to include services for the development of rapid, point-of-care diagnostics.
According to TTP, it previously contracted with Innova to develop a method of magnetic bead conjugation for antibody capture. Following Innova's successful production of conjugates within one week after receiving antibody materials, the companies now plan to jointly offer their services for the development of diagnostic or research assays to TTP customers.
Additional terms of the deal were not disclosed.